City
Epaper

China develops new mutant Covid strain with 100% death rate in humanised mice

By IANS | Updated: January 17, 2024 19:20 IST

Beijing, Jan 17 Scientists in China are experimenting with a mutant Covid-19 strain that can cause 100 per ...

Open in App

Beijing, Jan 17 Scientists in China are experimenting with a mutant Covid-19 strain that can cause 100 per cent death rate in "humanised" mice, according to a study not published yet.

The virus, dubbed GX_P2V caused 100 per cent mortality in human ACE2-transgenic mice, potentially due to late-stage brain infection, revealed the study published on preprint site bioRxiv, and not reviewed yet.

The study by researchers including from University of Chemical Technology and Nanjing University in China, showed that GX_P2V -- attacked the brains of mice that were engineered to reflect similar genetic makeup to people.

“This underscores a spillover risk of GX_P2V into humans and provides a unique model for understanding the pathogenic mechanisms of SARS-CoV-2-related viruses,” the researchers wrote in the paper.

The deadly GX_P2V is a mutated version of GX/2017 -- a coronavirus cousin that was reportedly discovered in Malaysian pangolins in 2017 -- three years before the pandemic.

All the mice that were infected with the virus died within just eight days, which researchers noted was a “surprisingly” rapid death rate, the New York Post reported.

The study showed that GX_P2V had infected the lungs, bones, eyes, tracheas, and brains of the dead mice, the last of which was severe enough to ultimately cause the death of the animals.

Days before their deaths, the mice had quickly lost weight, exhibiting a hunched posture, and moved extremely sluggish.

Even their eyes turned completely white the day before they died, the report said.

Experts slammed the research as “terrible” and “scientifically totally pointless.”

“I can see nothing of vague interest that could be learned from force-infecting a weird breed of humanised mice with a random virus. Conversely, I could see how much stuff might go wrong,” Francois Balloux, an epidemiology expert at the University College London’s Genetics Institute, wrote in a post on X.com.

“The preprint does not specify the biosafety level and biosafety precautions used for the research,” he continued.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalTwo-State solution to Palestinian 'near point of no return,' warns UN chief

Entertainment"It was a big thing for me...Shah Rukh Khan ne apni gadi chalane ko di": Tiku Talsania recalls his fond memories with SRK

InternationalCanadian, US leaders agree to meet in near future

InternationalUS urges India, Pak to 'not escalate' tensions

InternationalPiyush Goyal meets UK Foreign Secretary David Lammy in London

Health Realted Stories

HealthTwo nursing students killed as car runs amok in Telangana

HealthStar Health's profit crashes 99.76 pc in Q4

HealthAyush Ministry to hold national conclave to boost traditional healthcare delivery

HealthWorld Immunisation Week: Vaccines saved 38 million lives SE Asia, says WHO

HealthGujarat: Jan Aushadhi Kendra becomes a boon for Jamnagar people, offering medicines at low price